Results
Differentially Expressed miRNAs List
| miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
|---|---|---|---|---|---|---|---|---|
| hsa-miR-892b | GSE21036 | prostate cancer | prostate cancer | N/A | high grade vs low grade | -0.85 | DOWN | EXP00104 |
| hsa-miR-892b | GSE25820 | pancreatic cancer | pancreatic cancer | N/A | cancer vs normal | 3.50 | UP | EXP00134 |
| hsa-miR-892b | GSE25820 | pancreatic cancer | pancreatic cancer | N/A | cancer vs normal | 2.38 | UP | EXP00135 |
| hsa-miR-892b | GSE25820 | pancreatic cancer | pancreatic cancer | N/A | cancer vs normal | 2.99 | UP | EXP00136 |
| hsa-miR-892b | GSE30454 | colorectal cancer | colorectal cancer | N/A | cancer vs normal | 0.76 | UP | EXP00140 |
| hsa-miR-892b | GSE31629 | leukemia | leukemia | N/A | cancer vs normal | 0.70 | UP | EXP00149 |
| hsa-miR-892b | GSE37407 | breast cancer | breast cancer | N/A | metastasis | 0.03 | UP | EXP00161 |
| hsa-miR-892b | GSE32960 | nasopharyngeal cancer | nasopharyngeal cancer | N/A | cancer vs normal | 0.18 | UP | EXP00170 |
| hsa-miR-892b | GSE40525 | breast cancer | breast cancer | N/A | cancer vs normal | -0.85 | DOWN | EXP00190 |
| hsa-miR-892b | GSE40525 | breast cancer | breast cancer | N/A | cancer vs normal | -0.88 | DOWN | EXP00193 |
| hsa-miR-892b | GSE40525 | breast cancer | breast cancer | N/A | cancer vs normal | -0.88 | DOWN | EXP00194 |
| hsa-miR-892b | GSE40525 | breast cancer | breast cancer | N/A | cancer vs normal | -0.87 | DOWN | EXP00196 |
| hsa-miR-892b | GSE40525 | breast cancer | breast cancer | N/A | cancer vs normal | -0.83 | DOWN | EXP00197 |
| hsa-miR-892b | GSE37053 | lymphoma | lymphoma | N/A | subtype1 vs substype2 | 0.57 | UP | EXP00225 |
| hsa-miR-892b | GSE40345 | mesothelioma | mesothelioma | N/A | cancer vs normal | -1.85 | DOWN | EXP00234 |